Abou Family Residence (XTAE:ABOU) Debt-to-EBITDA : 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ABOU Abou Family Residence Ltd XTAE:ABOU
24 GF Score
Price ₪5.87
! 1 Warning Sign
View Full Analysis

What is Abou Family Residence Debt-to-EBITDA?

Abou Family Residence XTAE:ABOU +1.03% 24 Debt-to-EBITDA is 0.00 as of . 20. GuruFocus rates XTAE:ABOU with a GF Score™ of 24/100. The stock has 1 warning sign investors should review. Among 475 Medical Devices & Instruments companies, Abou Family Residence ranks worse than 210526.11% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Abou Family Residence's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₪0.00 Mil. Abou Family Residence's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₪0.00 Mil. Abou Family Residence's annualized EBITDA for the quarter that ended in . 20 was ₪0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Abou Family Residence's Debt-to-EBITDA or its related term are showing as below:

XTAE:ABOU's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.6
* Ranked among companies with meaningful Debt-to-EBITDA only.

Abou Family Residence  (XTAE:ABOU) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Abou Family Residence Debt-to-EBITDA Related Terms

Abou Family Residence Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Abou Family Residence's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abou Family Residence Debt-to-EBITDA Chart

Abou Family Residence Annual Data
Trend
Debt-to-EBITDA

Abou Family Residence Semi-Annual Data
Debt-to-EBITDA

XTAE:ABOU vs ABT, SYK, MDT: Debt-to-EBITDA Comparison

For the Medical Devices subindustry, Abou Family Residence's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abou Family Residence Debt-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abou Family Residence's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Abou Family Residence's Debt-to-EBITDA falls into.


XTAE:ABOU
24GF Score
Abou Family Residence Ltd XTAE:ABOU
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abou Family Residence Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Abou Family Residence's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=( + ) / N/A
=N/A

Abou Family Residence's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=( + ) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 0.00 mean?
Abou Family Residence (XTAE:ABOU) has a Debt-to-EBITDA of 0.00 as of . 20. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Abou Family Residence. According to the industry distribution chart, Abou Family Residence ranks #999999 out of 475 companies in the Medical Devices & Instruments industry.
Is Abou Family Residence's Debt-to-EBITDA too high?
Abou Family Residence's current Debt-to-EBITDA is 0.00. Based on the distribution chart, Abou Family Residence ranks #999999 out of 475 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Abou Family Residence has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Abou Family Residence's Debt-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Abou Family Residence ranks #999999 out of 475 companies for Debt-to-EBITDA. This places Abou Family Residence in the lower half of its industry. The industry median Debt-to-EBITDA is 1.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.60, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Abou Family Residence. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abou Family Residence's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abou Family Residence stock overvalued right now?
Abou Family Residence (XTAE:ABOU) has a current Debt-to-EBITDA of 0.00. The current Debt-to-EBITDA is 0.00. Abou Family Residence's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Abou Family Residence (XTAE:ABOU), the current Debt-to-EBITDA is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Abou Family Residence Business Description

Address 7 Haarad Street, Tel-Aviv, ISR, 6971060
Abou Family Residence Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.
24GF Score

Get the complete analysis for XTAE:ABOU

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪5.87
Price